Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2023; 13(9): 204-212


Hybrids based on coumarins and their anticancer activities: A bibliometric analysis

Wilson Cardona-Galeano, Howard Ramirez-Malule, David Gómez-Ríos.




Abstract
Cited by 0 Articles

Coumarins are a family of benzopyrones widely spread in the natural kingdom. These compounds have been related to beneficial effects on human health, e.g., reducing the risk of cancer, among other diseases. In this contribution, a bibliometric analysis based on the results of the Scopus database was performed. The Scopus database was selected for data collection, and VOSviewer 1.6.18 was used for data analysis and visualization. A total of 458 documents related to coumarins were indexed in Scopus in the timespan of 1993–2022. Articles and reviews related to coumarins showed a clear increase in the number of published papers per year between 2008 and 2022. The main areas of knowledge of those records were: (i) pharmacology, toxicology, and pharmaceutics, (ii) chemistry, and (iii) biochemistry, genetics, and molecular biology. Here, the studies have been focused on the synthesis of hybrid molecules based in coumarins, experimental studies of cytotoxicity and antiproliferative activity in cancer cell lines in vitro and in vivo, molecular docking as a tool for unveiling the molecular mechanisms of action and experimental absorption, distribution, metabolism, and excretion studies. The most productive countries in studies related to coumarin derivatives are currently India, China, and Egypt. Those countries also showed the most robust collaboration network.

Key words: coumarins, coumarin hybrids, anticancer activity, bibliometric analysis.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.